# US 10,319,475 B1 · Method and apparatus for determining relationships between medications and symptoms

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 10,319,475 B1
- Document ID: US10319475B1
- Status: Granted
- Kind: B1
- Application number: 14/739,723
- Filed: 2015-06-15
- Granted: 2019-06-11
- Earliest claimed: 2014-06-13
- Assignees: Enigami Systems, Inc.
- Applicants: Enigami Systems, Inc.
- Inventors: Clifton D. Croan; William F. Graf
- Web page: https://patentgrep.com/patent/US10319475B1

## CPC

- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- G06Q 10/10: Office automation; Time management
- G06Q 50/26: Government or public services (business processes related to the transportation industry G06Q50/40)
- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR

## Abstract

In accordance with one embodiment, a method can be implemented that includes enlisting via a computer network a plurality of participants to report one or more effects of their respective usage of a substance; confirming that a prospective participant is located in a state where use of the substance is legal; receiving from each of the one or more participants via the computer network one or more self-assessment reports of any physical, emotional, or mental responses or any combination thereof to the substance; and processing the one or more self-assessment reports with a computer processor to determine if the substance has an effect on a particular symptom or condition.

## Claims

### Claim 1

A method comprising:
enlisting via a computer network a plurality of participants to report one or more experienced effects from their respective cannabinoid usage;
confirming that a prospective participant is located in a jurisdiction where use of cannabinoids is legal;
receiving from each of the one or more participants via the computer network one or more self-assessment reports of one or more physical, emotional, or mental reported effects or one or more combination thereof from the use of at least one administered cannabinoid product wherein the at least one administered cannabinoid product is associated with a particular cannabinoid profile;
processing the one or more self-assessment reports with a computer processor to determine a cannabinoid or combination of cannabinoids having an effect on a particular symptom or medical condition; and
recommending an administration of a particular product to a consumer to treat the particular symptom or medical condition.

### Claim 2 (depends on 1)

The method of claim 1 wherein the processing the one or more self-assessment reports comprises:
statistically evaluating the one or more self-assessment reports with the computer processor to determine the cannabinoid or the combination of cannabinoids having the determined effect on the particular symptom or the particular medical condition.

### Claim 3 (depends on 1)

The method of claim 1 wherein not all of the plurality of participants participate from the same country.

### Claim 4 (depends on 1)

The method of claim 1 and wherein at least a portion of the participants participate anonymously.

### Claim 5 (depends on 1)

The method of claim 1 and further comprising:
reporting an efficacy rating for a particular cannabinoid product in producing a designated-effect, wherein the designated effect can be physical, mental, or emotional or any combination thereof.

### Claim 6 (depends on 1)

The method of claim 1 and further comprising:
certifying a particular cannabinoid or cannabinoid product as effective in treating a particular health condition or symptom.

### Claim 7 (depends on 1)

The method of claim 1 and further comprising:
certifying a particular cannabinoid or cannabinoid product as effective in producing a particular physical, emotional, or mental certified effect or any combination thereof.

### Claim 8 (depends on 1)

The method of claim 1 and further comprising:
providing a registration system for a cannabinoid manufacturer to register a cannabis product by product name and cannabinoid profile.

### Claim 9 (depends on 1)

The method of claim 1 wherein a participant can enter information about a cannabis product by product name and cannabinoid profile.

### Claim 10 (depends on 1)

The method of claim 1 and further comprising:
statistically analyzing the self-assessment reports with the computer processor to determine a combination of cannabinoids having an entourage effect.

### Claim 11 (depends on 1)

The method of claim 1 and further comprising:
statistically analyzing the self-assessment reports with the computer processor to determine a combination of one or more cannabinoids having a synergistic effect with an over the counter medication, a prescription medication, or a combination thereof.

### Claim 12 (depends on 1)

The method of claim 1 and further comprising:
certifying to an insurance company that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

### Claim 13 (depends on 1)

The method of claim 1 and further comprising:
certifying to a caregiver that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

### Claim 14 (depends on 1)

The method of claim 1 and further comprising:
certifying to a healthcare organization that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

### Claim 15 (depends on 1)

The method of claim 1 and further comprising:
certifying to a governmental entity that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

### Claim 16 (depends on 1)

The method of claim 1 and further comprising:
certifying to a commercial vendor that a particular cannabinoid or cannabinoid product is effective in treating a particular health condition or symptom based on a statistical analysis of the self-assessment reports.

### Claim 17 (depends on 1)

The method of claim 1 wherein the recommending comprises:
recommending to the consumer a cannabinoid, combination of cannabinoids, or cannabinoid product.

### Claim 18 (depends on 1)

The method of claim 1 wherein the recommending comprises:
recommending to the consumer one or more combinations of a cannabinoid, cannabinoid product, over the counter medication, or prescription medication.

### Claim 19 (depends on 17)

The method of claim 17 and further comprising:
determining a physical, emotional, or mental desired effect or any combination thereof desired by a consumer prior to the recommending.

### Claim 20 (depends on 1)

The method of claim 1 and further comprising:
inquiring with a participant about a cannabis product that the participant is not currently taking but has previously taken.

### Claim 21 (depends on 1)

The method of claim 1 wherein confirming that the prospective participant is located in a jurisdiction where use of cannabinoids is legal comprises checking the internet protocol address of the prospective participant.

### Claim 22 (depends on 2)

The method of claim 2 wherein the particular medical condition comprises a plurality of symptoms.

### Claim 23 (depends on 2)

The method of claim 2 and further comprising:
reporting based on the statistical evaluation of the self-assessment reports an efficacy rating for a particular cannabinoid product in producing a designated effect, wherein the designated effect can be physical, mental, or emotional or any combination thereof.

### Claim 24 (depends on 22)

The method of claim 22 and further comprising:
certifying a particular cannabinoid or cannabinoid product as effective in treating the particular medical condition or the particular symptom based on the statistical evaluation of the self-assessment reports.